1847 Holdings And 3 Other Stocks Under $1 Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insiders at four penny stocks, HOOKIPA Pharma Inc. (HOOK), 1847 Holdings LLC (EFSH), Organicell Regenerative Medicine, Inc. (OCEL), and Earth Science Tech, Inc. (ETST), have recently made notable purchases. HOOKIPA's CEO bought 10,000 shares, 1847 Holdings' 10% owner acquired 443,413 shares, Organicell's 10% owner purchased 320,710 shares, and Earth Science Tech's CEO bought 3,000 shares. These transactions may indicate the insiders' confidence in their companies' prospects.
July 12, 2023 | 11:32 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
1847 Holdings' 10% owner bought 443,413 shares at an average price of $0.23. The company projects a 54% YoY increase in Q2 revenue.
The significant purchase by a 10% owner, coupled with the company's strong revenue projection, could potentially boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Earth Science Tech's CEO bought 3,000 shares at an average price of $0.05. The company recently initiated the up-listing process to the OTCQB Exchange.
The CEO's purchase of shares, along with the company's up-listing process, could potentially boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
HOOKIPA Pharma's CEO bought 10,000 shares at an average price of $0.82. The company recently reported preliminary Phase 2 data on HB-200 in combination with pembrolizumab in patients with HPV16+ head and neck cancers.
The CEO's purchase of shares indicates confidence in the company's prospects, especially following the recent positive preliminary Phase 2 data. This could potentially drive the stock price up in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Organicell Regenerative Medicine's 10% owner bought 320,710 shares at an average price of $0.01. The company recently named a new Executive Vice President and Chief Science Officer.
The purchase by a 10% owner, along with the appointment of a new executive, could potentially increase investor confidence and drive the stock price up in the short term.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100